Lisdexamfetamine dimesylate and Ranibizumab ophthalmic
Determining the interaction of Lisdexamfetamine dimesylate and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lisdexamfetamine
Brand name: Vyvanse
Synonyms: Lisdexamfetamine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lisdexamfetamine dimesylate-Ranitidine
- Lisdexamfetamine dimesylate-Ranitidine Capsule
- Lisdexamfetamine dimesylate-Ranitidine Hydrochloride
- Lisdexamfetamine dimesylate-Ranitidine Injection
- Lisdexamfetamine dimesylate-Ranitidine Suspension
- Lisdexamfetamine dimesylate-Ranitidine Syrup
- Ranibizumab ophthalmic-Lisinopril
- Ranibizumab ophthalmic-Lisinopril and Hydrochlorothiazide
- Ranibizumab ophthalmic-Lisinopril Oral Solution
- Ranibizumab ophthalmic-Lisinopril Tablets
- Ranibizumab ophthalmic-Lispro-PFC
- Ranibizumab ophthalmic-Lithane